Scientists hunt for blood test to predict antidepressant success
NCT ID NCT02051413
Summary
This study aimed to find biological markers that could predict who will respond well to the antidepressant venlafaxine. Researchers followed 60 people with major depression and 20 healthy volunteers for three months. They measured specific proteins in the blood and linked them to changes in depression symptoms to see if a simple test could one day guide treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE EPISODE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Bicetre
Le Kremlin-Bicêtre, 94275, France
Conditions
Explore the condition pages connected to this study.